Advertisement
Alnylam Pharmaceuticals, Inc. (ALNY)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Follow
As of 11:35AM EST. Market open.
| Previous Close | 273.01 |
| Open | 273.01 |
| Bid | 248.94 x 200 |
| Ask | 272.30 x 100 |
| Day's Range | 270.04 - 275.07 |
| 52 Week Range | 141.98 - 304.39 |
| Volume | |
| Avg. Volume | 809,340 |
| Market Cap | 35.122B |
| Beta (5Y Monthly) | 0.39 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.62 |
| Earnings Date | Oct 31, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 306.62 |
Pharmaceutical TechnologyTop 20 biopharmas’ market cap rises 2% in Q3 2024 amid flurry of drug approvals
BMS witnessed the largest growth in market capitalisation of 24.6% to $105bn in Q3 2024.
BioPharma DiveAn RNAi renaissance is creating a new generation of startups
Pioneers like Alnylam Pharmaceuticals have led the RNA interference field for years. Now, a crop of young biotechs is building on that foundation by taking the drugmaking technology in new directions.
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.